Adma Biologics (ADMA) Net Cash Flow (2011 - 2025)
Adma Biologics (ADMA) posted Net Cash Flow of $26.2 million for Q4 2025, up 190.81% on a QoQ basis from -$28.9 million in Q3 2025, and up 59.64% year-over-year from $16.4 million in Q4 2024.
Adma Biologics (ADMA) Net Cash Flow (2011 - 2025) Analysis & Trends
Adma Biologics' Net Cash Flow history runs 13 years deep, the most recent figure standing at $26.2 million for Q4 2025.
- Quarterly Net Cash Flow rose 59.64% year-over-year to $26.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$15.5 million (down 129.96% YoY) and the FY2025 annual result came in at -$15.5 million, down 129.96% from the prior year.
- Net Cash Flow was $26.2 million for Q4 2025 at Adma Biologics, up from -$28.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $51.6 million in Q4 2022 and bottomed at -$31.5 million in Q1 2025.
- A 5-year average of $1.6 million and a median of -$3.8 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow jumped 741.44% — and 2025, when it plunged 1780.29%.
- Adma Biologics' Net Cash Flow stood at $16.7 million in 2021, then soared by 209.48% to $51.6 million in 2022, then sank by 144.18% to -$22.8 million in 2023, then surged by 172.09% to $16.4 million in 2024, then surged by 59.64% to $26.2 million in 2025.
- Business Quant data shows ADMA's Net Cash Flow at $26.2 million in Q4 2025, -$28.9 million in Q3 2025, and $18.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | 26.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.25 Mn |
| Dec 31, 2025 | 26.25 Mn |
| Sep 30, 2025 | -28.90 Mn |
| Sep 30, 2025 | -28.90 Mn |
| Jun 30, 2025 | 18.66 Mn |
| Jun 30, 2025 | 18.66 Mn |
| Mar 31, 2025 | -31.52 Mn |
| Mar 31, 2025 | -31.52 Mn |
| Dec 31, 2024 | 16.44 Mn |
| Dec 31, 2024 | 16.44 Mn |
| Sep 30, 2024 | -1.54 Mn |
| Sep 30, 2024 | -1.54 Mn |
| Jun 30, 2024 | 42.92 Mn |
| Jun 30, 2024 | 42.92 Mn |
| Mar 31, 2024 | -6.03 Mn |
| Mar 31, 2024 | -6.03 Mn |
| Dec 31, 2023 | -22.81 Mn |
| Dec 31, 2023 | -22.81 Mn |
| Sep 30, 2023 | 11.64 Mn |
| Sep 30, 2023 | 11.64 Mn |